AUTHOREA
Log in Sign Up Browse Preprints
LOG IN SIGN UP

Preprints

Explore 66,105 preprints on the Authorea Preprint Repository

A preprint on Authorea can be a complete scientific manuscript submitted to a journal, an essay, a whitepaper, or a blog post. Preprints on Authorea can contain datasets, code, figures, interactive visualizations and computational notebooks.
Read more about preprints.

Extreme warming restructures habitat distribution and productivity along local gradie...
Matthew Whalen
Sam Starko

Matthew Whalen

and 3 more

May 25, 2021
Significant questions remain about how ecosystems that are structured by abiotic stress will be affected by climate warming. A well-supported hypothesis states that warming will cause species to shift along abiotic gradients, such that distributions track changing local conditions. Here, we investigated the impacts of a multi-year heatwave on community dynamics and zonation in one such ecosystem: rocky intertidal communities. We demonstrate that, while populations generally shifted downslope towards reduced abiotic stress, species were impacted to varying degrees, leading to complex changes in community and ecosystem dynamics. Warming generally shifted primary production away from upper elevations through synchronized seaweed declines and replacement by invertebrates, while high producer biomass was maintained at lower elevations through compensatory dynamics that resulted in novel community composition. Our results illustrate that, rather than shifting community zonation uniformly along local gradients, warming will restructure habitat archetypes and redirect pathways for energy transfer in stress-structured systems.
Paediatric population pharmacokinetic and pharmacodynamic modelling of ambrisentan in...
Malek Okour
Mita Thapar

Malek Okour

and 5 more

May 25, 2021
Aims: To develop a population pharmacokinetic (PK) model of ambrisentan in paediatric patients aged 8 to <18 years with pulmonary arterial hypertension (PAH), compare paediatric ambrisentan systemic exposure to historical adult data, and assess PK–PD relationships. Methods: A previously developed adult population PK model provided an initial step for modelling the 211 PK observations from 39 paediatric patients with PAH in the randomised Phase IIb study AMB112529 (NCT01332331). Subsequently, a population PK model was developed using only paediatric PK data. Steady-state systemic exposure metrics were estimated for the paediatric population and compared with historical adult data (adult patients with PAH and healthy volunteers). Exploratory exposure–response analysis assessed ambrisentan systemic exposure versus change from baseline in 6-minute walking distance in paediatric patients; findings were compared with adult data. An exploratory analysis of ambrisentan exposure versus incidence of ambrisentan-related adverse events in paediatric patients was also performed. Results: The final paediatric population PK model was a two-compartment model which includes the effect of body weight (allometric scaling), first-order absorption and elimination, and absorption lag time. Similar steady-state ambrisentan exposure was confirmed in paediatric patients and historical adult data when differences in body weight were accounted for. There was no apparent correlation in the paediatric or adult population between ambrisentan exposure and change in 6-minute walking distance, or between ambrisentan exposure and incidence of ambrisentan-related adverse events in paediatric patients. Conclusions: Similar ambrisentan exposure and PK–PD profiles were observed in paediatric and adult populations with PAH.
H63D Syndrome: What we know about it in 2021 
Dr. Carolina Diamandis

Dr. Carolina Diamandis

and 8 more

May 25, 2021
H63D syndrome is a serious and clinically progressive disorder of iron metabolism caused by non-transferrin-bound iron (NTBI). In 2019, after scientists from around the world joined together to form the H63D Syndrome Research Consortium (a non-profit entity), a consensus paper "H63D Syndrome" was adopted at a meeting in Oslo in December 2019. With this new paper, we summarize what the leading experts in the field know about the syndrome in 2021.
A Single-Institution Experience in the Use of Chest Radiographs for Hospitalized Chil...
Ela Beyyumi
Mohamed Tawil

Ela Beyyumi

and 11 more

May 24, 2021
Background: Risks of cancer have become more notable lately, especially for young children with a chronic condition such as atopy. This study reports on cumulative radiation from chest radiographs in children with asthma. Its main aims were to consider our current practice, and suggest minimizing chest radiograph use in this vulnerable people. Methods: The study was retrospective and conducted at tertiary center. Eligibility criteria included children 2-15 y who were admitted between January-2017 and December-2018 for asthma management. Results: Of 643 children who were admitted as ‘asthma exacerbation’, 243 (40% females; age [mean±SD] 5.4±3.3 y) met the study criteria for inclusion. Ninety-two (38%) children had temperature 38.8±0.7oC on the day of admission. Antibiotics were prescribed for 148 (61%) children, mainly for presumed pneumonia. Chest radiographs were requested for 214 (88%) children, mainly on the day of admission. Only 38 (18%) chest radiographs showed focal/multifocal pneumonia justifying antibiotic use. Significant predictors for requesting chest radiographs were antibiotic use for presumed pneumonia, lower oxygen saturation at presentation, and requesting blood culture. Rate of chest radiographs per year was negatively related to child’s age; the younger the child the higher the rate (model coefficient -0.259, P<0.001). For children <5 y, rate of chest radiographs was 1.39±1.21/y and radiation dose 0.028±0.025 mSV/y. The corresponding rates for children ≥5 y were 0.78±0.72/y and 0.008±0.007 mSV/y, respectively (P<0.001). Conclusion: Chest radiographs were commonly requested for children with asthma, especially the young ones. Prospective studies are necessary to measure the impact of this practice on their health.
Effect of preoperative erector spinae muscles mass on postoperative outcomes in patie...
Yukiharu Sugimura
Nihat Sipahi

Yukiharu Sugimura

and 9 more

May 24, 2021
Background: Frailty influences the postoperative outcomes in patients undergoing left ventricular assist device (LVAD) implantation; however, a quantitative evaluation method has not been established. The purpose of the present study was to evaluate whether preoperative ESM mass is associated with short- and long-term clinical outcomes in patients with LVAD. Methods: A total of 119 consecutive patients with LVAD were enrolled between January 2010 and October 2017 at a single heart center. The ESM index and Hounsfield units (HU) of the ESM were calculated by computed tomography for preoperative ESM mass evaluation. We then statistically evaluated the in-hospital mortality, major adverse cardiovascular events (MACE), duration of hospital stay, and long-term survival. Results: In a multivariate Cox regression analysis, ESM index and HU of the ESM indicated no effect on the in-hospital mortality, MACE, and long-term survival. In addition, the ESM index presented a weak but significant negative linear correlation only with the duration of hospital stay (r = -0.21, p < 0.05). In contrast, the model for end-stage liver disease (MELD) score and preoperative venous-arterial extracorporeal membrane oxygenation (va-ECMO) were significant predictive factors for in-hospital mortality (MELD score: p < 0.001, hazard ratio [HR] 1.1; preoperative va-ECMO: p < 0.01, HR 2.72) and MACE (MELD score: p < 0.001, HR 1.07; preoperative va-ECMO: p < 0.005, HR 2.62). Conclusion: Preoperative ESM mass might predict the length of hospital stay in patients undergoing LVAD implantation. In contrast, it had no effect on MACE, in-hospital mortality, or long-term survival in this study.
STEMI due to septic embolism from prosthetic aortic valve Aspergillus spp. Endocardit...
coral Serrano Arroyo
Luis Sánchez Trujillo

coral Serrano Arroyo

and 5 more

May 24, 2021
A 65-year-old man with a history of aortic valve replacement surgery and non-coronary artery disease was admitted to the emergency department with acute ST-segment elevation myocardial infarction (STEMI). Coronary angiography revealed left anterior descending (LAD) artery occlusion, which was treated successfully with angioplasty. The patient developed obstructive valvular dysfunction, and large vegetation was observed on echocardiography. The patient subsequently developed irreversible septic shock and died several days later. The pathology report identified Aspergillus as the etiologic agent.
TRAIL-R1-targeted chimeric antigen receptor T cells exhibit dual antitumor effects
AiShun Jin
Yaru Nai

AiShun Jin

and 8 more

May 24, 2021
Tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) has limited expression in normal tissues but highly expression in a broad range of tumors, making it an attractive target for cancer immunotherapy. We have previously prepared a fully human monoclonal antibody targeting TRAIL-R1 (TR1419), which can specifically induce apoptosis in antigen-positive tumor cells. Here, we prepared the TR1419CAR-T cells using the single chain variable fragment (scFv) from TR1419, which were evaluated for the phenotypes and function. The TR1419CAR-T cells induced cytolysis of TRAIL-R1-positive tumor cells not only via activation of the death receptor-dependent apoptotic pathway, but also via T-cell mediated cytotoxicity. Furthermore, compared to the second-generation TR1419-28ζ and TR1419-BBζ CAR-T cells, the third-generation TR1419-28BBζ CAR-T cells had greater sensitivity to target antigen, exhibited a better proliferative ability, but showed slightly higher PD-1 expression after antigen stimulation. Altogether, TR1419CAR-T cells, especially TR1419-28BBζCAR-T cells could be a promising treatment strategy for TRAIL-R1 positive tumors.
Individual heterogeneity in fitness in a long-lived herbivore
Madeleine Lohman
Thomas Riecke

Madeleine Lohman

and 3 more

May 24, 2021
Heterogeneity in the intrinsic quality and nutritional condition of individuals affects reproductive success and consequently fitness. Understanding differences in energy allocation towards survival and reproduction within and among years might help explain variability in individual fitness. Black brant (Branta bernicla nigricans) are long-lived, migratory, specialist herbivores. Long migratory pathways and short summer breeding seasons constrain the time and energy available for reproduction, thus magnifying life-history trade-offs. These constraints, combined with long lifespans and trade-offs between current and future reproductive value, provide a model system to examine the role of individual heterogeneity in driving life-history strategies and individual heterogeneity in fitness. We used hierarchical Bayesian models to examine reproductive trade-offs, modeling the relationships between within-year measures of reproductive energy allocation and among-year demographic rates of individual females breeding on the Yukon-Kuskokwim Delta, Alaska using capture-recapture and reproductive data from 1988 to 2014. We provide evidence for relationships between breeding probability and clutch size (posterior mean of β = 0.45, 95% CRI = 0.33 – 0.57, SD = 0.06), breeding probability and nest initiation date (posterior mean of β = -0.12, 95% CRI = -0.2 ¬– -0.04, SD = 0.04), and an interaction between clutch size and initiation date (posterior mean of β = -0.12, 95% CRI = -0.2 – -0.04, SD = 0.04). Average lifetime clutch size also had a weak positive relationship with survival probability (posterior mean of β = 0.03, 95% CRI = -0.01 – 0.7, SD = 0.02). Our results support the use of demographic buffering strategies for black brant; reductions in reproductive energy allocation preserve high adult survival rates during years with poor environmental conditions, maximizing future reproductive value. We also indirectly show links among environmental conditions during growth, fitness, and energy allocation, highlighting the effects of early growth conditions on individual heterogeneity, and subsequently, reproductive investment.
Reduced infiltration of T-regulatory cells in tumours from mice fed daily with gamma-...
Shonia Subramaniam
Jeya Seela  Anandha Rao

Shonia Subramaniam

and 6 more

May 24, 2021
Gamma-tocotrienol (γT3) is an analogue of vitamin E with beneficial effects on the immune system, including immune-modulatory properties. This study reports the immune-modulatory effects of daily supplementation of γT3 on host T-helper (Th) and T-regulatory (Treg) populations in a syngeneic mouse model of breast cancer. Female BALB/c mice were fed with either γT3 or vehicle (soy oil) for 2-weeks via oral gavage before they were inoculated with syngeneic 4T1 mouse mammary cancer cells (4T1 cells). Supplementation continued until the mice were sacrificed. Mice (n=6) were sacrificed at specified time-points for various analysis (blood leucocyte, cytokine production, and immunohistochemistry). Tumour volume was measured once every seven days. Gene expression studies were carried out on tumour-specific T-lymphocytes isolated from splenic cultures. Supplementation with γT3 increased CD4+ (p<0.05), CD8+ (p<0.05) T-cells and natural killer cells (p<0.05) but suppressed Treg cells (p<0.05) in peripheral blood when compared to animals fed with the vehicle. Higher interferon-gamma (IFN) and lower transforming growth factor-beta (TGF-) levels were noted in the T3 fed mice. Immunohistochemistry findings revealed higher infiltration of CD4+ cells, increased expression of interleukin-12 receptor-beta-2 (IL-122R), interleukin-24 (IL-24) and reduced expression of cells that express the forkhead box P3 (FoxP3) in tumours from the T3 fed animals. Gene expression studies showed the downregulation of seven prominent genes in splenic CD4+ T-cells isolated from γT3-fed mice. Supplementation with γT3 from palm oil-induced T-cell dependent cell-mediated immune responses and suppressed Treg cells in the tumour microenvironment in a syngeneic mouse model of BC.
Neurological Complications Following Frozen Elephant Trunk for Aortic Dissection: Wha...
Sven Zhen Cian Patrick  Tan
Hazem  Elsantawy

Sven Zhen Cian Patrick Tan

and 2 more

May 24, 2021
Total arch repair (TAR) has become a mainstay of the surgical management of complex pathologies of the ascending aorta and aortic arch, in particular acute Type A aortic dissections (ATAAD). TAR with devices such as the frozen elephant trunk (FET) have been shown to dramatically improve clinical outcomes in such cases. However, TAR with FET remains an immensely challenging procedure, and the risk of debilitating postoperative complications remains high. Spinal cord ischaemia (SCI) and stroke are two particularly tragic adverse outcomes of TAR with FET; it is unsurprising therefore that much research has been done to determine both the underlying cause thereof, and strategies to mitigate this risk. Mousavizadeh and colleagues produced a fascinating systematic review and meta-analysis investigating the relationship between the duration of hypothermic circulatory arrest (HCA) and the risk of developing complications including SCI and stroke. Their data seem to suggest HCA duration is a key factor in causing SCI and stroke following TAR with FET for ATAAD. However, other factors such as stent sizing and landing zone also contribute. Further prospective research into this relationship is recommended to fully elucidate what truly is to blame for these postoperative neurological complications.
Left ventricular free wall rupture -- a real nightmare
Manuel J. Antunes

Manuel J. Antunes

May 24, 2021
Left ventricular free wall rupture (LVFWR) is a most rare but often lethal mechanical complication of acute myocardial infarction (AMI). The mortality rate for LVFWR is described from 75% to 90% and it is the cause for 20% of in-hospital deaths after AMI. Death results essentially from the limited time available for emergent intervention after onset of symptoms. Emergency surgery is indicated and normally the rupture site is easily identified, but it may not be apparent macroscopically, corresponding to transmyocardial or subepicardial dissection with an external rupture far from the infarction site, or already thrombosed and contained. Repair of the ventricular wall is usually achieved either by suturing the edges of the tear or closing it with patches of artificial material or biological tissues, usually using some kind of biological glue. However, several cases of successful conservative management have been described. In this Editorial, I comment on the metanalysis conducted by Matteucci et al, published in this issue of the Journal, including 11 non-randomized studies and enrolling a total of 363 patients, which brings a great deal of new knowledge that can help not only in the prevention but also in the management of this dreadful complication of AMI.
Respiratory outcomes at five-year follow-up in children with MBL deficiency: a cohort...
Manisha Ramphul
Anna Poghosyan

Manisha Ramphul

and 5 more

May 24, 2021
Introduction Mannose-binding lectin (MBL) serum protein, is an important molecule of the innate immune system that is involved in antimicrobial recognition and clearing responses. There is no conclusive evidence that MBL deficiency is associated with adverse respiratory consequences. Aim We explored whether there is a difference in clinical, radiological and microbiological characteristics in children with MBL deficiency presenting with troublesome respiratory symptoms (frequent, recurrent, persistent or very severe), as compared to those who are MBL-sufficient. Methods We performed a retrospective study looking at MBL measurements in children over a period of 10 years in a large teaching hospital, with a minimum follow-up period of 5 years from the time of the MBL measurement to the year 2019. Results 32% of children with MBL deficiency and 30% of those with MBL sufficiency had positive microbiology. 23% of children with MBL deficiency and 24% of those with MBL sufficiency had radiological changes on plain radiographs. 28% of children with MBL deficiency and 33% of those with MBL sufficiency had suboptimal vaccine responses to primary immunisations. 67% of the MBL-deficient children had suboptimal vaccine responses to booster immunisations, compared to 40% of the MBL-sufficient group. Conclusion We conclude that there is no difference at five year follow-up in clinical, radiological and microbiological characteristics between children who are MBL-deficient as compared to those who have sufficient levels. These results add to the existing body of literature that shows no statistically significant association between MBL deficiency and susceptibility to recurrent respiratory tract infection in children.
Spatiotemporal evolution of chlorophyll-a concentration from MODIS data inversion in...
zhuo Chen
ming Dou

zhuo Chen

and 4 more

May 24, 2021
The global construction of water projects has led to a clear trend of river and lake reservoir formation, spurring increasingly serious ecological environmental deterioration, especially that caused by the frequent occurrence of water blooms. Because of monitoring technology limitations, monitoring the algae content index in water has lagged behind the conventional water quality index, which makes sample monitoring too sparse in many rivers and the monitoring data incoherent, so it cannot truly reflect the evolution of water eutrophication. With moderate resolution imaging spectroradiometer (MODIS) remote sensing data monitoring, continuous chlorophyll-a observation data can be collected effectively. This method has important guiding significance for the early warning and control of water blooms. This study considers the middle and lower reaches of the Hanjiang River in China, based on the current remote sensing communication technology, MODIS remote sensing data, and statistical methods and measured chlorophyll-a concentration correlation analysis. Through the use of the trial and error method to establish the band ratio model and BP neural network model, two types of model errors were compared to determine the optimal algorithm settings for the middle and lower reaches of the Hanjiang River chlorophyll-a inversion. Subsequently, the algorithm model for 2000 to 2011 in the middle and lower reaches of the Hanjiang River chlorophyll-a concentration inversion and the results of the inversion analysis of spatiotemporal evolution characteristics we used to determine the influence of various environmental factors on the chlorophyll-a concentration change.
Biomarkers for the diagnosis and treatment of rheumatoid arthritis-a systematic revie...
dima abdelhafiz
Tara Baker

dima abdelhafiz

and 2 more

May 24, 2021
Background Rheumatoid Arthritis (RA) is an autoimmune disease, symmetrically affecting the small joints. Biomarkers are tools that can be used in the diagnosis and monitoring of RA. Aim To systematically explore the role of the biomarkers: C-reactive protein (CRP), Rheumatoid factor (RF), Anti-cyclic citrullinated protein (Anti-CCP), 14-3-3η and the multi-biomarker disease activity (MBDA) score for the diagnosis and treatment of RA. Methods A systematic review of the English literature using four different databases was carried out. Results CRP>7.1 mg/L predicted poor conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs) outcome in RA. Anti-CCP, CRP ≥0.3 mg/dL and RF predicted bone erosion and cartilage destruction. Combination of high 14-3-3η with RF and CRP improved the prediction of rapid erosion progression (REP). Anti-CCP was not associated with disease activity, but was associated with increased radiographic damage (r=0.46, p=0.048). RF was not associated with joint damage but correlated with ultrasound-detected bone erosion. 14-3-3η significantly correlated with inflammation, bone remodelling and osteoporosis in RA patients (p<0.05). 14 3 3η positively correlated with RA duration (p=0.003), disease activity and positive RF (P=0.025) and it distinguished early from established RA. Early MBDA scores correlated with later response in disease activity, after 6 and 12 weeks of treatment (p<0.05). MBDA score was able to differentiate between small differences in disease activity and predicted remission over one year period. Conclusion The investigated biomarkers are helpful tools in clinical practice for diagnosis, monitoring of treatment and predicting prognosis in RA patients. However, further research is still required to investigate novel biomarkers for the pre-treatment selection of potentially responsive patients before starting therapy for a precision medicine in this area.
Treatment of Helicobacter pylori in the Arab world: a systematic review and network m...
Shimaa Afify
Muhammad Abdel-Gawad

Shimaa Afify

and 18 more

May 24, 2021
Purpose: We aimed to conduct an updated systematic review and network meta-analysis (NMA) to estimate the efficacy of Helicobacter pylori (H. pylori) treatment strategies in Arab countries. Methods: We systematically searched PubMed, Scopus, Web of Science (WOS), EBSCO, and EMBASE from inception to July 18, 2020, using boolean operators. Retrieved articles were screened, and relevant data were extracted. We used R programming software to analyze extracted data. Results: Fifty-four articles (n= 7829 patients) were included in the NMA. Pooled overall analysis demonstrated that adjuvant therapy (standard triple or sequential therapy plus another adjuvant drug) was the best treatment with higher odds of eradication rate [OR= 6.42, 95% CI (1.37: 30.05), P-score= 0.21]. Moreover, Seqential therapy (SQT) and Quinolone based therapy (QBT) were associated with higher eradication rate compared to other regimens [OR= 4.83, 95% CI (1.49: 15.64), P-score= 0.30] and [OR= 4.32, 95% CI (1.15: 16.16), P-score= 0.36], respectively. In adults, the efficacy of QBT was higher than other stratigies in terms of H. pylori eradication [OR= 2.00, 95% CI (1.09, 3.69), P score= 0.19]. In naïve population, QBT and SQT were associated with substantial eradication rate [OR= 1.94, 95% CI (1.19: 3.16), P score=0.19] and [OR= 1.66, 95% CI (1.10: 2.50), P score=0.33], respectively. Conclusion: Our findings suggest that standard triple or sequential therapy plus another adjuvant drug, QBT and SQT therapies were the most effective regimens for eradicating H.pylori in Arab countries.
COVID-19 IN YOUNG AND MIDDLE-AGED ADULTS. PREDICTORS OF POOR OUTCOME AND CLINICAL DIF...
eva tabernero
Luis Alberto Ruiz

eva tabernero

and 11 more

May 24, 2021
ABSTRACT Young and middle-aged adults are the largest group of patients infected with SARS-CoV-2 and some of them develop severe disease. Objective: To investigate clinical manifestations in adults aged 18-65 years hospitalized for COVID-19 and identify predictors of poor outcome. Secondary objectives: to explore potential differences compared to the disease in elderly patients and the suitability of the commonly used community-acquired pneumonia prognostic scales in younger populations. Methods: Multicenter prospective registry of consecutive patients hospitalized for COVID-19 pneumonia aged 18-65 years between March and May 2020. We considered a composite outcome of “poor outcome” including intensive care unit admission and/or use of noninvasive ventilation, continuous positive airway pressure or high flow nasal cannula oxygen therapies and/or death. Results: We identified 513 patients <65 years of age, from a cohort of 993 patients. 102 had poor outcomes (19.8%) and 3.9% died. 78% and 55% of patients with poor outcomes were classified as low risk based on CURB and PSI scores respectively. A multivariate Cox regression model identified six independent factors associated with poor outcome: heart disease, chest pain, anosmia, low oxygen saturation, high LDH and lymphocyte count <800/mL. Conclusions: COVID-19 in younger patients carries significant morbidity and differs in some respects from this disease the elderly. Baseline heart disease is a relevant risk factor, while anosmia and pleuritic pain are more common and protective. Hypoxemia, LDH and lymphocyte count are predictors of poor outcome. We consider that CURB and PSI scores are not suitable criteria for deciding admission in this population.
Lifestyle Changes and Exacerbation Frequency of COPD in Times of the Pandemic
Fatma Tokgoz Akyil
Seda Tural Onur

Fatma Tokgoz Akyil

and 6 more

May 24, 2021
Aim: The aim of this study is to analyze COPD exacerbation rates and the effect of patients’ behavioral changes on the exacerbations during the pandemic. Materials and Methods: Conducted in a reference hospital for chest diseases, patients hospitalized with an exacerbation of COPD between 11.03.2019 and 11.03.2020 were designated. Patients’ COPD exacerbations requiring emergency department (ED) visits and/or hospitalization were compared between 11.03.2019 - 25.12.2019 (pre-pandemic period) and 11.03.2020 - 25.12.2020 (pandemic period). Each patient was surveyed with 25 questions using telemedicine. Results: Of all the 256 patients, 203 (79%) were male and the mean age was 66±10. Compared to the previous year, ED visits and hospitalizations in our hospital were significantly lower and less frequent (p<0.0001, for both). Smoking habit decreased in 9%, and 60% had hardly spent time in outdoors (e.g., parks and gardens). Only three patients reported to spend time indoors (e.g., cafes and restaurants). Household mask-use rate while contacting the patient was 50%. As a COPD patient, 33% expressed themselves as “feeling better”. Overall, 92 (36%) patients were recorded not to have any exacerbation, 34 (13%) to have no attacks of worsening that they were managed at home. Novel exacerbation risk was found to independently correlate with younger age (OR: 0.944,CI:0.904-0.986, p=0.010) and having more frequent episodes of exacerbation in the pre-pandemic period (OR:1.2,CI:1.025-1.405, p=0.023). Conclusion: COPD patients specifically benefited from confinements, restrictions and lifestyle changes. Further studies are needed to better identify the most critical factors leading to these positive outcomes. A permanent patient management guideline for COPD patients could be formulated where the weight of lifestyle factors is elevated.
Safety and feasibility of conduction system pacing in patients with congenital heart...
Oscar Cano
Gopi Dandamudi

Oscar Cano

and 12 more

May 24, 2021
Introduction: Conduction system pacing (CSP) has emerged as an ideal physiologic pacing strategy for patients with permanent pacing indications. We sought to evaluate the safety and feasibility of CSP in a consecutive series of unselected patients with congenital heart disease (CHD). Methods: Consecutive patients with CHD in which CSP was attempted were included. Safety and feasibility, implant tools and electrical parameters at implant and at follow-up were evaluated. Results: A total of 20 patients were included (10 with a previous device). Ten patients had complex forms of CHD, 9 moderate defects and 1 a simple defect. His bundle pacing (HBP) or left bundle branch area pacing (LBBAP) were achieved in all patients (10 HBP, 5 LBBP and 5 left ventricular septal pacing). Procedure times and fluoroscopy times were prolongued (126±82 min and 27±30 min, respectively). CSP lead implant times widely varied ranging from 4 to 115 minutes, (mean 31±28 min) and the use of multiple delivery sheaths was frequent (50%). The QRS width was reduced from 144±32 ms at baseline to 116±16 ms with CSP. Implant electrical parameters included: CSP pacing threshold 0.85±0.61V; R wave amplitude 9.8±9.2mV and pacing impedance 735±253 Ohms, and remained stable at a median follow-up of 478 days (IQR 225-567). Systemic ventricle systolic function and NYHA class (1.50±0.51 vs 1.10±0.31; p=0.008) significantly improved at follow-up. Lead revision was required in one patient at day-4. Conclusions: Permanent CSP is safe and feasible in patients with CHD although implant technique is complex.
Technical considerations in Hi-C scaffolding and evaluation of chromosome-scale genom...
Kazuaki Yamaguchi
Mitsutaka Kadota

Kazuaki Yamaguchi

and 5 more

May 24, 2021
The recent development of ecological studies has been fueled by the introduction of massive information based on chromosome-scale genome sequences, even for species for which genetic linkage is not accessible. This was enabled mainly by the application of Hi-C, a method for genome-wide chromosome conformation capture that was originally developed for investigating the long-range interaction of chromatins. Performing genomic scaffolding using Hi-C data is highly resource-demanding and employs elaborate laboratory steps for sample preparation. It starts with building a primary genome sequence assembly as an input, which is followed by computation for genome scaffolding using Hi-C data, requiring careful validation. This article presents technical considerations for obtaining optimal Hi-C scaffolding results and provides a test case of its application to a reptile species, the Madagascar ground gecko (Paroedura picta). Among the metrics that are frequently used for evaluating scaffolding results, we investigate the validity of the completeness assessment of chromosome-scale genome assemblies using single-copy reference orthologs, and report problems of the widely used program pipeline BUSCO.
Pregnancy and perinatal outcomes for women with Cystic Fibrosis: a UK population-base...
Oluwaseun Esan
Daniella Schlueter

Oluwaseun Esan

and 9 more

May 24, 2021
Objective To estimate the pregnancy rates and outcomes for women with cystic fibrosis (wwCF) in the UK compared to the general population and to explore the impact of the introduction of disease modifying treatments on pregnancy rates. Design A population-based cross-sectional study. Setting Electronic records of UK CF Registry Data (~99% of all CF), and conceptions data for England and Wales (E&W). Population All women aged 15-44 years who were pregnant between 2003-2017. Methods We calculated 3-yearly crude and age-specific pregnancy rates per 1,000 women years (wys), pregnancy rates for wwCF with a G551D mutation before and after Ivacaftor was introduced in 2012 and compared live birth rates. Main outcome measures Crude rates, age specific fertility, and maternal morbidity. Results The overall pregnancy rate was 23.5 (95% CI 21.9-25.3) per 1,000 wys, ~3.4fold difference to E&W women (77.7). This pattern was evident in the age specific rates, except for those aged 40-44 years where the difference in rates was much less (wwCF 8.2 per 1,000 wys vs. 13.3 in E&W). LB rate differences mirrored pregnancy rates (wwCF 17.4 per 1000 wys vs. 61.4 E&W women). Following the introduction of Ivacaftor, pregnancy rates in wwCF with G551D increased from 29.5 to 56.9 per 1000wys (2012-2014 to 2015-2017). Conclusions Pregnancy rates in wwCF are about a third of the rates in the general population but on the rise following the introduction of Ivacaftor. There is no indication that there is a reduced chance of a live birth in wwCF who become pregnant.
Obstacle course for our toys
Jimena Ferreyros

Jimena Ferreyros

May 24, 2021
This lesson is managed for kids in nursery (3-4 years old), so they can learn through playing about STEAM. I'm going to concentrate in the area of construction and recycling because in my opinion, kids can learn a lot using those things.Children in early childhood can develop a love for STEM and a feeling of efficacy for their own abilities that can support their learning. Using their own toys we can capture the child's love for science, math, engineering, arts and technology. Also encouraging them to explorate and to be curious through insightful questions and celebrating secces as well as failure, so they can go on and on investigating. Goal:Create obstacles of all type to a course that the kids have to build in their neighborhood, in orther to learn about how important it is to mantaine clean the streets, the green parts and the enviroment.Materials:Toys for construction (legos, blocks, among others).Recycled materials for construction (boxes, toilet paper tubes, paperboard, among others).Paper, colored pencils, tape and other tools to decorate the course and neighborhood.Toys to play after you finish with your construction (vehicles, persons, animals and plants).
Development of the Swiss Database for Dosing Medicinal Products in Paediatrics
Romy Tilen
Dalibor Panis

Romy Tilen

and 5 more

May 23, 2021
In daily paediatrics, drugs are commonly used off-label, as they are not approved for children. Approval is lacking because the required clinical studies were limited to adults in the past. Without clinical studies, evidence-based recommendations for drug use in children are limited. In the meantime, paediatric regulation came into force where the approval of new drugs requires clinical studies in children. Still, most of the drugs currently prescribed to children are not yet covered by this new regulation. Information on drug dosing in children can be found in different handbooks, databases, and scientific publications but the dosing recommendations can differ considerably. Accordingly, prescribing medicines to children remains a challenge. To improve drug safety and efficacy in children and assist the prescribers, stakeholders in Swiss paediatrics started a pilot project, supported by the Federal Office of Public Health, with the aim to create a database, providing healthcare professionals with so called “harmonised” dosage recommendations based on national consensus. A standardised process for dosage harmonisation was defined, guided, and documented in an electronic tool, developed for this purpose thereby integrating the latest available scientific evidence and best clinical practice for optimal dosage recommendations. As proof of principle, a total of 102 dosage recommendations for 30 different drugs have been nationally harmonised in the pilot phase considering the current literature and the consent of the most experienced national experts in the field. This approach paved the way for unified national dosage recommendations for children.
Neonatal outcomes after neuraminidase inhibitor use during pregnancy: a meta-analysis...
Jiangshan Lian
Munire  Adilijiang

Jiangshan Lian

and 4 more

May 23, 2021
AIM: Influenza infection poses a severe threat to pregnant mothers, and antiviral treatment is recommended. However, the safety of neuraminidase-inhibitor antiviral medications during pregnancy has not been well described. METHODS: A systematic review and meta-analysis were performed to evaluate the adverse neonatal outcomes associated with exposure to neuraminidase inhibitors during pregnancy. The PubMed, Embase, and Cochrane Library databases were searched to identify potential studies for inclusion. RESULTS: Nine cohort studies that estimated adverse neonatal outcomes associated with exposure to neuraminidase-inhibitor medication during pregnancy were included. Exposure to a neuraminidase inhibitor during pregnancy was not associated with an increased risk of congenital malformation (odds ratio [OR] 0.9, 95% confidence interval [CI] 0.72–1.12, P = 0.341), low Apgar score (OR 0.96, 95% CI 0.77–1.2, P = 0.733), or preterm birth (OR 0.99, 95% CI 0.89–1.09, P = 0.771) compared with no exposure. However, exposure to a neuraminidase inhibitor was associated with a reduced risk of low birth weight (OR 0.79, 95% CI 0.68–0.92, P = 0.002) and giving birth to a small-for-gestational-age infant (OR 0.78, 95% CI 0.69–0.88, P < 0.001). Further analyses limited to oseltamivir exposure were consistent with the overall results. CONCLUSION: Exposure to neuraminidase-inhibitor medication during pregnancy does not appear to be associated with adverse neonatal outcomes. We recommend further studies to investigate this association, which will help clinicians determine whether to prescribe a neuraminidase inhibitor during pregnancy.
Emergency Cardiac Surgery in Patients on Oral Anticoagulants and Antiplatelet Medicat...
Rami Akhrass
A. Marc Gillinov

Rami Akhrass

and 7 more

May 23, 2021
Emergency surgery, blood transfusion, and reoperation for bleeding have been associated with increased operative morbidity and mortality. The recent increased use of direct oral anticoagulants and antiplatelet medications have made the above more challenging. In addition, cardiopulmonary bypass (CPB) with its associated hemodilution, fibrinolysis and platelet consumption may exacerbate the pre-existing coagulopathy and increase the risk of bleeding. Management decisions are typically made on a case-by-case basis. Surgery is delayed when possible and less invasive percutaneous options should be considered if feasible. Attention is paid to exercising meticulous techniques, avoiding excessive hypothermia and treating coexisting issues such as sepsis. Ensuring a dry operative field upon entry by correcting the coagulopathy with reversal agents is offset by the concern of potentially hindering efforts to anticoagulate the patient (heparin resistance) in preparation for CPB, in addition to possibly increasing the risk of thromboembolism. Proper knowledge of the anticoagulants, their reversal agents, and the usefulness of laboratory testing are all essential. Platelet transfusion remains mainstay for antiplatelet medications. Four-factor prothrombin complex concentrate is considered in patients on oral anticoagulants if CPB needs to be instituted quickly. Specific reversal agents such as idarucizumab and andexanet alfa can be considered if significant tissue dissection is anticipated such as redo sternotomy, but are costly and may lead to heparin resistance and anticoagulant rebound.
← Previous 1 2 … 2142 2143 2144 2145 2146 2147 2148 2149 2150 … 2754 2755 Next →

| Powered by Authorea.com

  • Home